Education
About Us
Working with TipRanks
Follow Us
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
APVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.94 - $51.06
Previous CloseN/A
Volume25.11K
Average Volume (3M)3.80M
Market Cap
$3.26M
Enterprise Value$2.20M
Total Cash (Recent Filing)$4.64M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.35
Next Earnings
May 08, 2025EPS Estimate
-4.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-452.26
Shares Outstanding3,223,214
10 Day Avg. Volume11,232,252
30 Day Avg. Volume3,796,498
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.09
Forecast
1Y Price Target
$21.00Price Target Upside1919.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Aptevo Therapeutics News
PremiumCompany Announcements
Aptevo Therapeutics Achieves Remission Success in AML Trial
PremiumCompany Announcements
Aptevo Therapeutics Showcases Promising Oncology Drug Pipeline
---
Ownership Overview
3.34% Insiders
<0.01% Mutual Funds
1.76% Other Institutional Investors
94.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
APVO FAQ
What was Aptevo Therapeutics Inc’s price range in the past 12 months?
Aptevo Therapeutics Inc lowest stock price was $0.94 and its highest was $51.06 in the past 12 months.
What is Aptevo Therapeutics Inc’s market cap?
Aptevo Therapeutics Inc’s market cap is $3.26M.
When is Aptevo Therapeutics Inc’s upcoming earnings report date?
Aptevo Therapeutics Inc’s upcoming earnings report date is May 08, 2025 which is in 23 days.
How were Aptevo Therapeutics Inc’s earnings last quarter?
Aptevo Therapeutics Inc released its earnings results on Feb 14, 2025. The company reported -$8.94 earnings per share for the quarter, missing the consensus estimate of -$7.75 by -$1.19.
Is Aptevo Therapeutics Inc overvalued?
According to Wall Street analysts Aptevo Therapeutics Inc’s price is currently Undervalued.
Does Aptevo Therapeutics Inc pay dividends?
Aptevo Therapeutics Inc does not currently pay dividends.
What is Aptevo Therapeutics Inc’s EPS estimate?
Aptevo Therapeutics Inc’s EPS estimate is -4.21.
How many shares outstanding does Aptevo Therapeutics Inc have?
Aptevo Therapeutics Inc has 3,223,214 shares outstanding.
What happened to Aptevo Therapeutics Inc’s price movement after its last earnings report?
Aptevo Therapeutics Inc reported an EPS of -$8.94 in its last earnings report, missing expectations of -$7.75. Following the earnings report the stock price went down -8.242%.
Which hedge fund is a major shareholder of Aptevo Therapeutics Inc?
Currently, no hedge funds are holding shares in APVO
---
Company Description
Aptevo Therapeutics Inc
Aptevo Therapeutics (APVO) is a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics aimed at providing innovative treatments for cancer and other life-threatening diseases. The company operates primarily in the biotechnology and pharmaceutical sectors, leveraging its proprietary ADAPTIR and ADAPTIR-FLEX platforms to create bispecific antibody therapeutics. Aptevo's core products include APVO436, a bispecific antibody candidate targeting acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), among other developmental candidates.
---
APVO Stock 12 Month Forecast
Average Price Target
$21.00
▲(1919.23% Upside)
Technical Analysis
Best Analysts Covering APVO
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-77.37%
reiterated a buy rating 2 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -77.37% per trade.
---